As of October 2026 ImmunityBio has a market cap of A$15.66 Billion. This makes ImmunityBio the world's 1887th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Oct 3rd, 2026 the market cap of ImmunityBio was reported to be: